31A Stock Forecast - Theravet SA

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 0.076 EUR

Market Cap: €4.7m

	Theravet SA F:31A	BE

Wall St Price Targets

There are no price targets for 31A.

31A Lowest Forecast

31A Average Forecast

31A Highest Forecast

Amper SA

30% Upside

Evolus Inc

80% Upside

Nephrocare Health Services Ltd

15% Upside

Amper SA

30% Upside

Evolus Inc

80% Upside

Nephrocare Health Services Ltd

15% Upside

Continue 31A Research

Summary

Wall St Estimates

Discount Rate

PAR • EUR

ALVET

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

31A does not have any price targets made by Wall Street professionals.

Back to Top

Join 354,200+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.